Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in Bandung, Indonesia. [PDF]
PLoS Neglected Tropical Diseases, 2013 BackgroundAll four serotypes of dengue virus are endemic in Indonesia, where the population at risk for infection exceeds 200 million people. Despite continuous control efforts that were initiated more than four decades ago, Indonesia still suffers from ...
Panji Fortuna Hadisoemarto +1 more
doaj +17 more sources
Is new dengue vaccine efficacy data a relief or cause for concern? [PDF]
npj Vaccines, 2023 Dengue is a major global public health problem requiring a safe and efficacious vaccine as the foundation of a comprehensive countermeasure strategy. Despite decades of attempts, the world has a single dengue vaccine licensed in numerous countries, but ...
Stephen J. Thomas
doaj +2 more sources
Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
Molecules, 2021 Approximately 100–400 million people from more than 100 countries in the tropical and subtropical world are affected by dengue infections. Recent scientific breakthroughs have brought new insights into novel strategies for the production of dengue ...
Harun Norshidah +2 more
exaly +3 more sources
Acceptability of a hypothetical dengue vaccine and the potential impact of dengue vaccination on personal vector control behavior: a qualitative study in Fortaleza, Brazil [PDF]
BMC Public Health, 2023 Background Dengue is the most rapidly spreading viral vector-borne disease in the world. Promising new dengue vaccines have contributed to a growing consensus that effective dengue control will require integrated strategies of vaccination and vector ...
Valerie K. Scott +3 more
doaj +2 more sources
Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity [PDF]
Vaccines, 2023 Dengue fever, an infectious disease that affects more than 100 million people every year, is a global health problem. Vaccination may be the most effective prevention strategy for the disease.
Ramil R. Mintaev +6 more
doaj +2 more sources
Advancing dengue vaccine development: Challenges, innovations, and the path toward global protection [PDF]
Pediatric InvestigationDengue fever remains a significant global health threat, placing nearly half of the world's population at risk. Despite decades of research, developing an effective dengue vaccine continues to face multiple challenges, including antibody‐dependent ...
Ran Wang +3 more
doaj +2 more sources
BMC Infectious Diseases, 2020 Background Dengue fever is a major public health problem in Colombia. A fever surveillance study was conducted for evaluation of the clinical, epidemiological, and molecular patterns of dengue, prior to Chikungunya and Zika epidemics. Methods In November
Jacqueline Kyungah Lim +8 more
doaj +1 more source
Role of humoral versus cellular responses induced by a protective dengue vaccine candidate. [PDF]
PLoS Pathogens, 2013 With 2.5 billion people at risk, dengue is a major emerging disease threat and an escalating public health problem worldwide. Dengue virus causes disease ranging from a self-limiting febrile illness (dengue fever) to the potentially fatal dengue ...
Raphaël M Zellweger +5 more
doaj +1 more source
The Infectious Disease Ontology in the Age of COVID-19 [PDF]
, 2021 The Infectious Disease Ontology (IDO) is a suite of interoperable ontology modules that aims to provide coverage of all aspects of the infectious disease domain, including biomedical research, clinical care, and public health.
Babcock, Shane +3 more
core +1 more source
Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement. [PDF]
PLoS Neglected Tropical Diseases, 2013 BACKGROUND: Dengue virus is a mosquito-transmitted virus that can cause self-limiting dengue fever, severe life-threatening dengue hemorrhagic fever and dengue shock syndrome.
Chen-Yi Chiang +9 more
doaj +1 more source